Phase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics
Type de publicationJournal Article
Year of Publication2015
AuteursKaspers GJL, Niewerth D, Wilhelm B, Ramnarain S, Berkhof H, de Haas V, Mathot RAA, Attarbaschi A, Baruchel A, de Bont ES, Fagioli F, Rossig C, Klingebiel T, De Moerloose B, Nelken B, Palumbo G, Reinhardt D, Rohrlich PSimon, Simon P, Stackelberg A, C. Zwaan M
JournalBLOOD
Volume126
Date PublishedDEC 3
Type of ArticleMeeting Abstract
ISSN0006-4971